A case of lepromatous leprosy with multiple relapses.
نویسندگان
چکیده
We report a case of multiple relapses in a lepromatous leprosy patient after treatment with World Health Organisation (WHO) recommended multibacillary multidrug therapy (MBMDT). The patient responded well to reintroduction of MDT after each relapse.
منابع مشابه
De-Novo Presentation of Histoid Leprosy on an Unusual Site
Histoid Leprosy (HL) is a rare variant of Lepromatous Leprosy, occurring in long-standing cases, mostly in a background of acquired drug resistance. Patients usually present with sudden onset multiple nodules and plaques, most often involving the skin and subcutaneous tissue of trunk and lower limbs. Here we report an unusual case of de novo (without any history of prior anti-leprotic therapy) ...
متن کاملTuberculoid relapse in lepromatous leprosy.
TUBERCULOID RELAPSE IN LEPROMATOUS LEPROSY Sir, Waters & Ridley ' recently reported 6 patients who had been lepromatous and who, after many years of chemotherapy and bacteriological negativity, were found on relapse to have upgraded to borderline-tuberculoid (BT) leprosy . In a related article,2 they reported the development of weakly posi tive lepromin reactions in some lepromatous patients tr...
متن کاملTwo microbiological relapses in a patient with lepromatous leprosy.
A lepromatous patient treated with dapsone in the pre-MDT era to the point of smear negativity (> 6 years), relapsed 5 years after stopping treatment. He was then put on WHO-MDT for multibacillary (MB) leprosy, and was treated again; he had negative slit skin smears (3 years). He again presented with a relapse of leprosy 17 years after stopping treatment, and this time he presented with borderl...
متن کاملRelapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
The Schieffelin Leprosy Research and Training Center at Karigiri, India participated in several of the World Health Organization (WHO) trials. The first trial on combined therapy in multi-bacillary leprosy was initiated in 1981. The main objectives of this field trial were to evaluate the efficacy of WHO recommended regimens in preventing relapses, especially drug resistance relapses. This pape...
متن کاملLangerhans Cells in Skin Lesions of Leprosy
Background: Langerhans cells are important in the pathogenesis of leprosy. A recent study reported that these cells were almost absent in the epidermis overlying lepromatous lesions. Objective: To investigate a possible relationship between the number of Langerhans cells and the histopathologic spectrum of lesions in patients with leprosy. Methods: An immunohistochemical staining for S100 prot...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Leprosy review
دوره 80 2 شماره
صفحات -
تاریخ انتشار 2009